Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
How does Spotify Wrapped calculate your listening age? What your number says about you. - 2Financial plan Cordial Home Redesigns That Add Worth
- 3The race is on to turn your body into a GLP-1 factory
- 4Help Your Insusceptibility: Good dieting and Way of life Tips
- 5PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- Best Augmented Simulation Ride: Which One Feels Generally Genuine?
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- Ifo: Job cuts in Germany slowing but not enough for a turnaround
- Study reveals links between global food systems, obesity, and climate change
- Record-breaking flu hospitalizations in New York in a single week: Health officials
- Fact Check: Israeli Channel 13, Al Jazeera Did NOT Confirm Hezbollah Captured All Or Part Of Kiryat Shmona
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
